{ "cik": 1557746, "cik_padded": "0001557746", "entityName": "Aclaris Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001104659-26-020540", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 111000.0, "cash": 19960000.0, "eps_diluted": -0.53, "free_cash_flow": -47224000.0, "net_income": -64923000.0, "operating_cash_flow": -47113000.0, "operating_income": -76375000.0, "revenue": 7826000.0, "stockholders_equity": 103082000.0, "total_assets": 160460000.0, "total_liabilities": 57378000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5566248229564813, "revenue_growth_yoy": -0.5819444444444445, "roa_avg2y": -0.3409937839264471, "roa_period_end": -0.40460550916116167, "roe_avg2y": -0.5020414791444346, "roe_period_end": -0.6298189790652102 } }, { "accn": "0001104659-26-020540", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 121000.0, "cash": 24570000.0, "eps_diluted": -1.71, "free_cash_flow": -20196000.0, "net_income": -132065000.0, "operating_cash_flow": -20075000.0, "operating_income": -141932000.0, "revenue": 18720000.0, "stockholders_equity": 155554000.0, "total_assets": 220327000.0, "total_liabilities": 64773000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4164020211630688, "revenue_growth_yoy": -0.4009408301065634, "roa_avg2y": -0.6322953472561356, "roa_period_end": -0.5994045214612825, "roe_avg2y": -0.8445862764722623, "roe_period_end": -0.8489977756920426 } }, { "accn": "0001558370-25-001819", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1309000.0, "cash": 39878000.0, "eps_diluted": -1.27, "free_cash_flow": -79634000.0, "net_income": -88481000.0, "operating_cash_flow": -78325000.0, "operating_income": -97357000.0, "revenue": 31249000.0, "stockholders_equity": 157179000.0, "total_assets": 197405000.0, "total_liabilities": 40226000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2559247736656933, "revenue_growth_yoy": 0.05031594514654477, "roa_avg2y": -0.3915079833894173, "roa_period_end": -0.44822066310377146, "roe_avg2y": -0.49876550169109357, "roe_period_end": -0.562931434860891 } }, { "accn": "0001558370-25-001819", "filed": "2025-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 605000.0, "cash": 45277000.0, "eps_diluted": -1.33, "free_cash_flow": -68172000.0, "net_income": -86908000.0, "operating_cash_flow": -67567000.0, "operating_income": -89854000.0, "revenue": 29752000.0, "stockholders_equity": 197621000.0, "total_assets": 254596000.0, "total_liabilities": 56975000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2883043806073241, "revenue_growth_yoy": 3.400532465611596, "roa_avg2y": -0.34364095396070043, "roa_period_end": -0.3413565020660183, "roe_avg2y": -0.44008284341278403, "roe_period_end": -0.4397710769604445 } }, { "accn": "0001558370-24-001753", "filed": "2024-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 308000.0, "cash": 27349000.0, "eps_diluted": -1.6, "free_cash_flow": -52442000.0, "net_income": -90865000.0, "operating_cash_flow": -52134000.0, "operating_income": -89723000.0, "revenue": 6761000.0, "stockholders_equity": 197341000.0, "total_assets": 251211000.0, "total_liabilities": 53870000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27297925925175204, "revenue_growth_yoy": 0.04304227090404196, "roa_avg2y": -0.5643876457708971, "roa_period_end": -0.3617078869953943, "roe_avg2y": -0.7733487665485062, "roe_period_end": -0.4604466380529135 } }, { "accn": "0001558370-24-001753", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 453000.0, "cash": 22063000.0, "eps_diluted": -1.2, "free_cash_flow": -39086000.0, "net_income": -51015000.0, "operating_cash_flow": -38633000.0, "operating_income": -50912000.0, "revenue": 6482000.0, "stockholders_equity": 37650000.0, "total_assets": 70784000.0, "total_liabilities": 33134000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8800531208499336, "revenue_growth_yoy": 0.5334752779749231, "roa_avg2y": -0.6034385886054613, "roa_period_end": -0.7207137206148282, "roe_avg2y": -0.9485691973001618, "roe_period_end": -1.354980079681275 } }, { "accn": "0001558370-23-001829", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1613000.0, "cash": 34187000.0, "eps_diluted": -3.9, "free_cash_flow": -98058000.0, "net_income": -161354000.0, "operating_cash_flow": -96445000.0, "operating_income": -111058000.0, "revenue": 4227000.0, "stockholders_equity": 69912000.0, "total_assets": 98297000.0, "total_liabilities": 28385000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.40601041309074265, "revenue_growth_yoy": -0.31279466753373436, "roa_avg2y": -0.8631718035751064, "roa_period_end": -1.6414946539568858, "roe_avg2y": -1.1321657615178433, "roe_period_end": -2.3079585764961665 } }, { "accn": "0001558370-22-001838", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1356000.0, "free_cash_flow": -102167000.0, "net_income": -132738000.0, "operating_cash_flow": -100811000.0, "operating_income": -84780000.0, "revenue": 6151000.0, "stockholders_equity": 215124000.0, "total_assets": 275566000.0, "total_liabilities": 60442000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.280963537308715, "revenue_growth_yoy": 2.6547831253713605, "roa_avg2y": -0.5114405432740934, "roa_period_end": -0.48169222618174956, "roe_avg2y": -0.602825702906087, "roe_period_end": -0.6170301779438835 } }, { "accn": "0001558370-21-001717", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1235000.0, "cash": 20202000.0, "free_cash_flow": -55898000.0, "net_income": -68523000.0, "operating_cash_flow": -54663000.0, "operating_income": -54361000.0, "revenue": 1683000.0, "stockholders_equity": 225262000.0, "total_assets": 243509000.0, "total_liabilities": 18247000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08100345375607071, "roa_avg2y": -0.32661572853758636, "roa_period_end": -0.2813982234742864, "roe_avg2y": -0.3471698686770428, "roe_period_end": -0.3041924514565262 } }, { "accn": "0001558370-20-001325", "filed": "2020-02-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 232000.0, "cash": 30171000.0, "free_cash_flow": -34835000.0, "net_income": -48079000.0, "operating_cash_flow": -34603000.0, "operating_income": -48567000.0, "stockholders_equity": 169490000.0, "total_assets": 176085000.0, "total_liabilities": 6595000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03891085019765178, "roa_period_end": -0.2730442683931056, "roe_period_end": -0.28366865301787714 } }, { "accn": "0001558370-18-001866", "filed": "2018-03-12", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "cash": "USD" }, "fundamentals": { "cash": 9851000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001104659-26-020540", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001557746.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001557746.json" }, "ticker": "ACRS" }